CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• OP. Inc. Y/Y Annual
Cardiff Lexington Corporation  (CDIF)
Other Ticker:  
 
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

CDIF's Operating Income Growth by Quarter and Year

Cardiff Lexington's Operating Income results by quarter and year




CDIF Operating Income (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter December 0.33 0.51 -1.63 3.29
III Quarter September -0.59 2.27 1.50 1.07
II Quarter June -0.16 1.71 1.10 -2.36
I Quarter March 0.22 0.71 0.72 -0.38
FY   -0.20 5.20 1.69 1.62



CDIF Operating Income fourth quarter 2024 Y/Y Growth Comment
Cardiff Lexington Corporation reported fall in Operating Income in the fourth quarter 2024 by -34.87% to $ 0.33 millions, from the same quarter in 2023.
The drop in the fourth quarter 2024 Cardiff Lexington Corporation's Operating Income compares unfavorably to the Company's average Operating Income growth of 6.11%.

Looking into fourth quarter 2024 results within Healthcare Facilities industry 3 other companies have achieved higher Operating Income growth. While Cardiff Lexington Corporation' s Operating Income drop of -34.87% ranks overall at the positon no. 264 in the fourth quarter 2024.

Explain Operating Income growth


CDIF Operating Income ( Y/Y Growth %) 2024
 2023 2022 2021
IV Quarter December -34.87 % - - -
III Quarter September - 51.33 % 40.19 % -
II Quarter June - 55.45 % - -
I Quarter March -69.01 % -1.39 % - -
FY   - 207.69 % 4.32 % -

Financial Statements
Cardiff Lexington's fourth quarter 2024 Operating Income $ 0.33 millions CDIF's Income Statement
Cardiff Lexington's fourth quarter 2023 Operating Income $ 0.51 millions Quarterly CDIF's Income Statement


CDIF Operating Income (Quarter on Quarter Growth %)

 2024
 2023 2022 2021
IV Quarter December - -77.53 % - 207.48 %
III Quarter September - 32.75 % 36.36 % -
II Quarter June - 140.85 % 52.78 % -
I Quarter March -56.86 % - -78.12 % -
FY (Year on Year)   - 207.69 % 4.32 % -


Compare CDIF Profitability >> Back to CDIF Growth rate Comparisons >>


Operating Income fourth quarter 2024 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #4
Healthcare Sector #27
Overall #264

Operating Income Y/Y Growth Statistics
High Average Low
207.04 % 6.11 % -103.72 %
(Dec 31 2023)   (Dec 31 2024)
Operating Income fourth quarter 2024 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #4
Healthcare Sector #27
Overall #264
Operating Income Y/Y Growth Statistics
High Average Low
207.04 % 6.11 % -103.72 %
(Dec 31 2023)   (Dec 31 2024)

Operating Income by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Cardiff Lexington's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CDIF's IV. Quarter Q/Q Operating Income Comment
This turnaround IV. Quarter 2024where Cardiff Lexington Corporation posted Operating Income of $ 0.33 millions may be considered as a inception of improved performance.Cardiff Lexington Corporation announced in the IV. Quarter 2024 Operating Income of $ 0.33 millions compare to Operating Loss recorded in previos quarter.

Within Healthcare Facilities industry Cardiff Lexington Corporation achieved highest sequential Operating Income growth. While Cardiff Lexington's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CDIF's IV. Quarter Q/Q Operating Income Comment
This reversal of fortune IV. Quarter 2024where Cardiff Lexington Corporation published Operating Income of $ 0.33 millions should be considered as a starting point of positive business climet.Cardiff Lexington Corporation announced in the IV. Quarter 2024 Operating Income of $ 0.33 millions compare to Operating Loss recorded in previos quarter.

Within Healthcare Facilities industry Cardiff Lexington Corporation achieved highest sequential Operating Income growth. While Cardiff Lexington's Operating Income growth quarter on quarter, overall rank is .


Cardiff Lexington's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Dec 31 2024)		 12 Months Ending
(Sep 30 2024)		 12 Months Ending
(Jun 30 2024)		 12 Months Ending
(Mar 31 2024)		 12 Months Ending
(Dec 31 2023)
Cumulative Operating Income 12 Months Ending $ -0.19 $ -0.02 $ 2.83 $ 4.70 $ 5.20
Y / Y Operating Income Growth (TTM) - - 24.03 % 179.43 % 207.04 %
Year on Year Operating Income Growth Overall Ranking # 88 # 1680 # 1942 # 1359 # 815
Seqeuential Operating Income Change (TTM) - - -39.69 % -9.52 % 69.97 %
Seq. Operating Income Growth (TTM) Overall Ranking # 264 # 428 # 447 # 819 # 1648


Cumulative Operating Income growth Comment
Cardiff Lexington Corporation realized trailing twelve months Operating Loss of $ 0 millions, in the Dec 31 2024, compare to Operating Income of $ 5 millions a year ago.

Among companies within the Healthcare sector 9 other companies have achieved higher trailing twelve month Operating Income growth. While Total ranking has impoved so far to 88, from total ranking in previous quarter at 1680.

Operating Income TTM Q/Q Growth Statistics
High Average Low
207.04 %
6.11 %
-103.72 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 4
Healthcare Sector # 10
Overall # 88

Operating Income TTM Y/Y Growth Statistics
High Average Low
207.04 %
6.11 %
-103.72 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 4
Sector # 27
S&P 500 # 264
Cumulative Operating Income growth Comment
Cardiff Lexington Corporation realized trailing twelve months Operating Loss of $ 0 millions, in the Dec 31 2024, compare to Operating Income of $ 5 millions a year ago.

Among companies within the Healthcare sector 9 other companies have achieved higher trailing twelve month Operating Income growth. While Total ranking has impoved so far to 88, from total ranking in previous quarter at 1680.

Operating Income TTM Q/Q Growth Statistics
High Average Low
207.04 %
6.11 %
-103.72 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 4
Healthcare Sector # 10
Overall # 88

Operating Income TTM Y/Y Growth Statistics
High Average Low
207.04 %
6.11 %
-103.72 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 4
Sector # 27
S&P 500 # 264




Other Operating Income Growth
Healthcare Facilities Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
CDIF's Operating Income Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for CDIF's Competitors
Operating Income Growth for Cardiff Lexington's Suppliers
Operating Income Growth for CDIF's Customers

You may also want to know
CDIF's Annual Growth Rates CDIF's Profitability Ratios CDIF's Asset Turnover Ratio CDIF's Dividend Growth
CDIF's Roe CDIF's Valuation Ratios CDIF's Financial Strength Ratios CDIF's Dividend Payout Ratio
CDIF's Roa CDIF's Inventory Turnover Ratio CDIF's Growth Rates CDIF's Dividend Comparisons



Companies with similar Operating Income drop for the quarter ending Dec 31 2024 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Dec 31 2024
West Pharmaceutical Services Inc -0.81%$ -0.808 millions
Integra Lifesciences Holdings Corp-1.17%$ -1.168 millions
Neurocrine Biosciences Inc -5.52%$ -5.522 millions
Sanofi-7.91%$ -7.911 millions
Protokinetix Incorporated-8.86%$ -8.855 millions
Alkermes Plc -8.90%$ -8.897 millions
Sanuwave Health Inc -12.00%$ -12.003 millions
Dexcom Inc -12.91%$ -12.909 millions
Community Health Systems Inc -15.24%$ -15.244 millions
Artivion Inc -15.86%$ -15.858 millions
Align Technology inc -15.97%$ -15.970 millions
Ironwood Pharmaceuticals inc -16.22%$ -16.223 millions
Sotera Health Company-16.23%$ -16.225 millions
Lantheus Holdings Inc -17.18%$ -17.176 millions
Dariohealth Corp -17.92%$ -17.918 millions
National Research Corporation-18.11%$ -18.106 millions
Corcept Therapeutics Inc-20.23%$ -20.234 millions
Nature s Sunshine Products inc -20.29%$ -20.287 millions
Utah Medical Products Inc-29.91%$ -29.906 millions
Alpha Pro Tech Ltd -30.59%$ -30.587 millions
Edwards Lifesciences Corporation-32.14%$ -32.142 millions
Cardiff Lexington Corporation-34.27%$ -34.271 millions
Embecta Corp -36.92%$ -36.923 millions
Siga Technologies Inc-37.73%$ -37.731 millions
Collegium Pharmaceutical Inc -38.22%$ -38.220 millions
Bio rad Laboratories Inc -38.80%$ -38.804 millions
Acadia Healthcare Company Inc -39.92%$ -39.923 millions
Royalty Pharma Plc-41.02%$ -41.015 millions
3m Company-41.03%$ -41.030 millions
Inmode Ltd -42.49%$ -42.486 millions


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com